Filed with ASX ·
On 6ix: 6ix.com/news/board-renewal-3
Watch Botanix Pharmaceuticals' latest callBotanix Pharmaceuticals (ASX:BOT) Q2 2026 Earnings Call · Replay · Mar 2Read the transcript of Botanix Pharmaceuticals (ASX:BOT) Q2 2026 Earnings Call
19 October 2026 Board Renewal PHOENIX USA, 19 October 2026: Commercial dermatology company, Botanix Pharmaceuticals Limited (ABN 70 009 109 755) (ASX:BOT, “Botanix” or “the Company”), advises that Australian resident Non-Executive Directors Dr Stewart Washer and Mr Danny Sharp resigned from...
6ix hasn’t read this filing yet.
Botanix Pharmaceuticals Limited on 6ix
Follow Botanix Pharmaceuticals into a list and get an email when it puts out news.
Follow Botanix Pharmaceuticals